Clinical Trial

Physical Activity Levels and Musculoskeletal Health Among Health Science Academicians at Istanbul Aydin University

Study acronym: PA-ACAD-IAU
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the relationship between physical activity levels and posture, sleep quality, depression, and musculoskeletal system problems among academic staff working in the health sciences field at Istanbul Aydın University. Modern technological developments and sedentary work patterns have significantly reduced daily physical activity levels. Academic personnel often spend long hours sitting, preparing lectures, conducting research, and using computers, which may negatively affect posture and increase the risk of musculoskeletal pain. Reduced physical activity has also been associated with poor sleep quality and increased depressive symptoms. This cross-sectional study will include academic staff aged 23-65 years working in the Faculty of Health Sciences. Participation will be voluntary. Data will be collected using a sociodemographic information form and validated assessment tools, including the International Physical Activity Questionnaire-Short Form (IPAQ), New York Posture Rating Chart, Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and the Nordic Musculoskeletal Questionnaire. The primary objective is to evaluate whether physical activity levels are associated with posture, sleep quality, depression levels, and musculoskeletal complaints. The findings are expected to contribute to the development of preventive strategies aimed at improving occupational health, well-being, and quality of life among academic personnel.
Trial Details
NCT Number NCT07445100
Lead Sponsor Istanbul Aydın University
Conditions Musculoskeletal Diseases, Depression, Sleep Wake Disorders, Posture
Enrollment 73 participants
Start Date 2026-03
Primary Completion 2026-04 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-03